Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients
G Mustacchi, F Puglisi, AM Molino, D Crivellari… - Future …, 2015 - Taylor & Francis
Aim: This observational study investigates the use of adjuvant trastuzumab (AT) in HER2-
positive breast cancer patients in a real-life setting, focusing on relapse and discontinuation …
positive breast cancer patients in a real-life setting, focusing on relapse and discontinuation …